INVESTORS: NEWS RELEASES

CHANGING THE FUTURE

News Releases

Co-Diagnostics Announces Closing of Debt Financing

SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today the closing of a non-convertible debt instrument for $2M. The...

read more

Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States

1 (801) 438-1036

info@codiagnostics.com

© 2016-2018 Co-Diagnostics, Inc. • All Rights Reserved.

LATEST NEWS RELEASE

Co-Diagnostics is a molecular diagnostics company with a unique mathematical approach to DNA test design. Our products offer a unique value proposition, making the detection of infectious disease and genetic disorders far more affordable worldwide.

Click here to learn more

Co-Diagnostics, Inc.
2401 South Foothill Dr, Suite D
Salt Lake City, Utah 84109
United States

1 (801) 438-1036

info@codiagnostics.com

COMPANY

© 2016-2018 Co-Diagnostics, Inc. • All Rights Reserved.